Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus/Rapamycin vs Tacrolimus/Methotrexate for GVHD Prophylaxis
NCT00803010Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Sep 2008
- Primary completion
- Dec 2012
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-sirolimus in graft-versus-host disease (GVHD), sponsored by Moffitt Cancer Center. Started Sep 2008; status: completed.
02
Drugs
nab-sirolimus
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00803010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803010.